Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:1232-1237

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braam, B.
Right arrow Articles by Mitchell, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braam, B.
Right arrow Articles by Mitchell, K. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LOSARTAN POTASSIUM

(Hypertension. 1995;25:1232-1237.)
© 1995 American Heart Association, Inc.


Articles

Modulation of Tubuloglomerular Feedback by Angiotensin II Type 1 Receptors During the Development of Goldblatt Hypertension

Branko Braam; L. Gabriel Navar; Kenneth D. Mitchell

From the Department Nephrology and Hypertension, University Hospital Utrecht, Netherlands (B.B.), and the Department of Physiology, Tulane University School of Medicine, New Orleans, La.

Correspondence to K.D. Mitchell, PhD, Department of Physiology, SL 39, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112.

Abstract It has been suggested that the increased levels of angiotensin II (Ang II) in the contralateral kidney of two-kidney, one clip (2K1C) Goldblatt hypertensive rats act to enhance tubuloglomerular feedback responsiveness and proximal tubular reabsorption and thereby exert a substantial sodium-retaining influence on the nonclipped kidney. The current study investigated the Ang II dependency of tubuloglomerular feedback responsiveness in the nonclipped kidney during the early stages of development of 2K1C hypertension. Stop-flow pressure feedback responses were assessed in the nonclipped kidney of 2K1C rats during control conditions and after systemic administration of the Ang II type 1 receptor antagonist losartan (10 mg/kg). In 1-week clipped and sham-operated rats, losartan administration decreased mean arterial pressure (from 143±6 to 123±2 mm Hg, P<.01, and from 129±2 to 106±5 mm Hg, P<.01, respectively) and attenuated the magnitude of the maximal feedback responses (from -12.9±1.2 to -3.0±0.3 mm Hg, P<.01, and from -13.2±1.5 to -3.6±1.1 mm Hg, P<.01, respectively). The decreases in mean arterial pressure were not significantly different in sham-operated and 1-week clipped rats. In 3-week clipped rats, mean arterial pressure was further elevated (163±6 mm Hg) compared with sham-operated rats (134±4 mm Hg, P<.01). Although maximal tubuloglomerular feedback responses were similar in 3-week clipped and sham-operated rats, the late proximal perfusion rate eliciting a half-maximal response averaged 13±2 nL/min in the 3-week clipped and 18±1 nL/min in the sham-operated rats (P<.05), indicating enhanced tubuloglomerular feedback responsiveness in the nonclipped kidney. After losartan administration, mean arterial pressure decreased by 32±5 and 43±3 mm Hg, and the maximal tubuloglomerular feedback responses were markedly attenuated in both the sham-operated rats (from -12.3±1.9 to -2.4±0.9 mm Hg, P<.01) and clipped rats (from -9.6±0.6 to -1.8±0.5 mm Hg, P<.01). These data indicate that during the early stages of 2K1C Goldblatt hypertension, tubuloglomerular feedback responsiveness in the nonclipped kidney is maintained or slightly enhanced and highly dependent on Ang II type 1 receptor activation.


Key Words: renal circulation • receptors, angiotensin • hypertension, renovascular • rats, Sprague-Dawley • losartan




This article has been cited by other articles:


Home page
HypertensionHome page
V. D. Ramseyer and J. L. Garvin
Angiotensin II Decreases Nitric Oxide Synthase 3 Expression via Nitric Oxide and Superoxide in the Thick Ascending Limb
Hypertension, February 1, 2009; 53(2): 313 - 318.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. D. Mitchell and J. J. Mullins
Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1210 - F1216.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. L. Zhuo, J. D. Imig, T. G. Hammond, S. Orengo, E. Benes, and L. G. Navar
Ang II Accumulation in Rat Renal Endosomes During Ang II-Induced Hypertension: Role of AT1 Receptor
Hypertension, January 1, 2002; 39(1): 116 - 121.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Cervenka, H. J. Kramer, J. Maly, and J. Heller
Role of nNOS in Regulation of Renal Function in Angiotensin II-Induced Hypertension
Hypertension, August 1, 2001; 38(2): 280 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. TURKSTRA, B. BRAAM, and H. A. KOOMANS
Impaired Renal Blood Flow Autoregulation in Two-Kidney, One-Clip Hypertensive Rats Is Caused by Enhanced Activity of Nitric Oxide
J. Am. Soc. Nephrol., May 1, 2000; 11(5): 847 - 855.
[Abstract] [Full Text]


Home page
HypertensionHome page
E. Turkstra, P. Boer, B. Braam, and H. A. Koomans
Increased Availability of Nitric Oxide Leads to Enhanced Nitric Oxide Dependency of Tubuloglomerular Feedback in the Contralateral Kidney of Rats With 2-Kidney, 1-Clip Goldblatt Hypertension
Hypertension, October 1, 1999; 34(4): 679 - 684.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Cervenka, C.-T. Wang, K. D. Mitchell, and L. G. Navar
Proximal Tubular Angiotensin II Levels and Renal Functional Responses to AT1 Receptor Blockade in Nonclipped Kidneys of Goldblatt Hypertensive Rats
Hypertension, January 1, 1999; 33(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Zhuo, M. Ohishi, and F. A. O. Mendelsohn
Roles of AT1 and AT2 Receptors in the Hypertensive Ren-2 Gene Transgenic Rat Kidney
Hypertension, January 1, 1999; 33(1): 347 - 353.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Ichihara, J. D. Imig, and L. G. Navar
Neuronal Nitric Oxide Synthase-Dependent Afferent Arteriolar Function in Angiotensin II-Induced Hypertension
Hypertension, January 1, 1999; 33(1): 462 - 466.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. G. Navar, L. Zou, A. Von Thun, C. Tarng Wang, J. D. Imig, and K. D. Mitchell
Unraveling the Mystery of Goldblatt Hypertension
Physiology, August 1, 1998; 13(4): 170 - 176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Cervenka, C.-T. Wang, and L. G. Navar
Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats
Am J Physiol Renal Physiol, May 1, 1998; 274(5): F940 - F945.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L.-X. Zou, J. D. Imig, A. M. Von Thun, A. Hymel, H. Ono, and L. G. Navar
Receptor-Mediated Intrarenal Angiotensin II Augmentation in Angiotensin II–Infused Rats
Hypertension, October 1, 1996; 28(4): 669 - 677.
[Abstract] [Full Text]